Back to BAILLIE GIFFORD & CO BAILLIE GIFFORD & CO

CLOVCLOV
9 quarters

Position history for BAILLIE GIFFORD & COBAILLIE GIFFORD & CO's holdings in CLOVER HEALTH INVESTMENTS CORP

No. Baillie Gifford exited its CLOV (Clover Health Investments) position in Q1 2023. Its Q4 2022 13F listed 2,645,503 shares worth $2.5M. Baillie Gifford already held CLOV in its Q1 2021 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$38.9M

Total Shares Change

-5.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q1
Latest
Exited
0
-100.0%
$00.0%$0.82
0
2022-Q4
Unchanged
2.6M
0.0%
$2.5M0.0%$0.93
0
2022-Q3
Unchanged
2.6M
0.0%
$4.5M0.0%$1.80
0
2022-Q2
Decreased
2.6M
-66.0%
$5.7M0.0%$2.17
0
2022-Q1
Unchanged
7.8M
0.0%
$27.6M0.0%$3.65
0
2021-Q4
Increased
7.8M
+51.5%
$29M0.0%$3.84
40
2021-Q3
Unchanged
5.1M
0.0%
$38M0.0%$7.40
0
2021-Q2
Unchanged
5.1M
0.0%
$68.5M0.0%$13.36
0
2021-Q1
New
5.1M
-
$38.9M0.0%$7.19
40

Other major holders of CLOV: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used